1. A High-Fat Diet and NAD+ Activate Sirt1 to Rescue Premature Aging in Cockayne Syndrome
- Author
-
Scheibye-Knudsen, Morten, Mitchell, Sarah J, Fang, Evandro F, Iyama, Teruaki, Ward, Theresa, Wang, James, Dunn, Christopher A, Singh, Nagendra, Veith, Sebastian, Hasan-Olive, Md Mahdi, Mangerich, Aswin, Wilson, Mark A, Mattson, Mark P, Bergersen, Linda H, Cogger, Victoria C, Warren, Alessandra, Le Couteur, David G, Moaddel, Ruin, Wilson, David M, Croteau, Deborah L, de Cabo, Rafael, and Bohr, Vilhelm A
- Subjects
Aging ,Neurosciences ,Brain Disorders ,Genetics ,Nutrition ,Intellectual and Developmental Disabilities (IDD) ,Complementary and Integrative Health ,2.1 Biological and endogenous factors ,Aetiology ,3-Hydroxybutyric Acid ,Aging ,Premature ,Animals ,Cell Line ,Cockayne Syndrome ,Diet ,High-Fat ,Enzyme Activation ,Humans ,Mice ,Mice ,Inbred C57BL ,Mitochondria ,NAD ,Poly (ADP-Ribose) Polymerase-1 ,Poly(ADP-ribose) Polymerases ,Sirtuin 1 ,Biochemistry and Cell Biology ,Medical Biochemistry and Metabolomics ,Endocrinology & Metabolism - Abstract
Cockayne syndrome (CS) is an accelerated aging disorder characterized by progressive neurodegeneration caused by mutations in genes encoding the DNA repair proteins CS group A or B (CSA or CSB). Since dietary interventions can alter neurodegenerative processes, Csb(m/m) mice were given a high-fat, caloric-restricted, or resveratrol-supplemented diet. High-fat feeding rescued the metabolic, transcriptomic, and behavioral phenotypes of Csb(m/m) mice. Furthermore, premature aging in CS mice, nematodes, and human cells results from aberrant PARP activation due to deficient DNA repair leading to decreased SIRT1 activity and mitochondrial dysfunction. Notably, β-hydroxybutyrate levels are increased by the high-fat diet, and β-hydroxybutyrate, PARP inhibition, or NAD(+) supplementation can activate SIRT1 and rescue CS-associated phenotypes. Mechanistically, CSB can displace activated PARP1 from damaged DNA to limit its activity. This study connects two emerging longevity metabolites, β-hydroxybutyrate and NAD(+), through the deacetylase SIRT1 and suggests possible interventions for CS.
- Published
- 2014